Big Pharma. Can public health coexist with economic interests?
Claire Lasko, Luc Hermann
An international study of the major pharmaceutical companies that have a monopoly on the world market. From the scandals of recent decades, such as the case of Depakin, for the treatment of epilepsy, to the staggering price hike, to the current scenarios of Covid-19.
The “financialization” of the pharmaceutical industry is the real evil that is undermining the sector and, consequently, the health perspective of citizens.